Hims & Hers (NYSE: HIMS) CMO sells 23,726 shares, retains 181,861

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison reported an open-market sale of Class A Common Stock. He sold 23,726 shares at a price of $35.00 per share. After this transaction, he directly holds 181,861 shares of the company’s Class A Common Stock.

Insights

Insider trading analyst

CMO makes a moderate open-market share sale while retaining a sizable stake.

The Chief Medical Officer of Hims & Hers Health, Patrick Harrison, conducted an open-market sale of 23,726 shares of Class A Common Stock at $35.00 per share. The transaction is coded as an open-market sale, indicating a discretionary disposition.

Following the sale, he directly owns 181,861 shares, so he continues to have substantial equity exposure. There are no derivative positions listed, suggesting this filing reflects only common stock holdings. Overall, this appears to be a routine liquidity event rather than a transformational change.

Insider Trade Summary 10b5-1

Net Seller: 23,726 shares ($830,410)

Net Sell 1 txn

Insider Carroll Patrick Harrison

Role Chief Medical Officer

Sold 23,726 shs ($830K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	23,726	$35.00	$830K

Holdings After Transaction: Class A Common Stock — 181,861 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 23,726 shares Sale price per share: $35.00 per share Shares owned after sale: 181,861 shares +1 more

4 metrics

Shares sold 23,726 shares Open-market sale of Class A Common Stock

Sale price per share $35.00 per share Price received in the open-market sale

Shares owned after sale 181,861 shares Direct Class A Common Stock holdings post-transaction

Net share change -23,726 shares Net-sell direction from transactionSummary

Key Terms

Form 4, open-market sale, Class A Common Stock, Chief Medical Officer

4 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open-market sale financial

""transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Class A Common Stock financial

""security_title": "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Chief Medical Officer financial

""officer_title": "Chief Medical Officer""

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/23/2026 - 06:39 PM Accepted by SEC EDGAR 06/23/2026 - 06:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carroll Patrick Harrison

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/18/2026		S		23,726	D	$35	181,861	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HIMS Chief Medical Officer report on this Form 4?

Hims & Hers Health Chief Medical Officer Patrick Harrison reported an open-market sale of 23,726 shares of Class A Common Stock at $35.00 per share. This Form 4 discloses a single, discretionary sale transaction by a senior executive in the company.

How many HIMS shares did the CMO sell and at what price?

Patrick Harrison sold 23,726 shares of Hims & Hers Health Class A Common Stock at a price of $35.00 per share. The sale was reported as an open-market transaction, meaning the shares were sold on the market rather than through a private agreement.

How many HIMS shares does the CMO hold after this reported sale?

After the reported transaction, the Chief Medical Officer directly owns 181,861 shares of Hims & Hers Health Class A Common Stock. This post-transaction balance shows he still maintains a significant equity position in the company despite the recent sale.

Was the HIMS CMO transaction a buy or sell according to the Form 4?

According to the Form 4 data, the transaction by Hims & Hers Health Chief Medical Officer Patrick Harrison was a sale. It is coded as an open-market sale, reflecting a disposal of 23,726 shares rather than an acquisition or option exercise event.

Does the HIMS Form 4 show any option exercises or derivative positions for the CMO?

The Form 4 excerpt shows no derivative transactions or remaining derivative positions for Patrick Harrison. The derivativeSummary is empty, and the only reported activity is a non-derivative open-market sale of common stock, focusing solely on Class A Common Stock holdings.